---
title: "Whitepaper – Improving the predictive power of GPCR assays: Revealing hidden pharmacology"
description: "Whitepaper – Improving the predictive power of GPCR assays: Revealing hidden pharmacology"
image: https://info.edifydigitalmedia.com/hubfs/Euorfins%20Featured%20Image%20HS%20-%2005.10.26.png
---

[Skip to content](https://info.edifydigitalmedia.com/whitepaper-improving-the-predictive-power-of-gpcr-assays-revealing-hidden-pharmacology#main-content)

[![DDW Hi Res Logo](https://info.edifydigitalmedia.com/hs-fs/hubfs/DDW%20Hi%20Res%20Logo.jpg?width=250&height=118&name=DDW%20Hi%20Res%20Logo.jpg "DDW Hi Res Logo")](https://www.edifydigitalmedia.com/)

![Eurofins Landing Page Banner - 05.10.26-1](https://info.edifydigitalmedia.com/hs-fs/hubfs/CMP%20images/Eurofins%20CMP%20Whitepaper%20-%2005.11.26/Eurofins%20Landing%20Page%20Banner%20-%2005.10.26-1.jpg?width=2000&height=561&name=Eurofins%20Landing%20Page%20Banner%20-%2005.10.26-1.jpg "Eurofins Landing Page Banner - 05.10.26-1")

**How much of your compound's activity are your assays really detecting?**

Understanding how receptor density impacts pharmacological responses is critical for accurately characterising compound activity & identifying candidates with the highest likelihood of therapeutic success.

![Eurofins CMP Asset Image - 05.11.26](https://info.edifydigitalmedia.com/hs-fs/hubfs/CMP%20images/Eurofins%20CMP%20Whitepaper%20-%2005.11.26/Eurofins%20CMP%20Asset%20Image%20-%2005.11.26.jpg?width=173&height=225&name=Eurofins%20CMP%20Asset%20Image%20-%2005.11.26.jpg)

Explore this whitepaper by GPCR expert Terry Kenakin, PhD, and Eurofins DiscoverX® to discover how tuning receptor density and system sensitivity can reveal hidden efficacies, improve agonist and antagonist characterisation, and deliver more predictive pharmacology.

**Key Learnings:**

• Quantify agonist affinity & efficacy with inducible cell lines usage

• Characterise antagonists & their hidden efficacies

• Reveal candidate profiles including allosteric molecules likely to translate into in vivo therapeutic success

 

Brought to you by 

![Eurofins\_Scientific\_Logo.svg](https://info.edifydigitalmedia.com/hs-fs/hubfs/CMP%20images/Eurofins%20CMP%20Whitepaper%20-%2005.11.26/Eurofins_Scientific_Logo.svg.webp?width=244&height=50&name=Eurofins_Scientific_Logo.svg.webp) 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Copyright 2026 Drug Discovery World. All Rights Reserved  
[Privacy Policy & Cookies](https://www.ddw-online.com/privacy-policy/) | [Contact](https://info.edifydigitalmedia.com/hubfs/In%20Focus%20eReport_Mar26_Antibody-based%20drugs.pdf?hsLang=en) | [Terms & Conditions](https://www.ddw-online.com/terms-and-conditions/)